amlodipine pharmaswiss 10 mg
mediline ltd. - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.
noritate cream 1 %
mediline ltd. - metronidazole 10 mg/g - cream - metronidazole - for topical treatment of inflammatory lesions and erythema of rosacea.
alopexy
mediline ltd. - minoxidil 2 % - solution - minoxidil - androgenetic alopecia in males and females.
sandoglobuline i.v 1 g
mediline ltd. - immunoglobulin normal human 1 g/vial - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinaemia or hypogammaglobulinaemia). idiopathic thrombocytopenic purpura (itp).
sandoglobuline i.v 6 g
mediline ltd. - immunoglobulin normal human 6 g/vial - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinaemia or hypogammaglobulinaemia). idiopathic thrombocytopenic purpura (itp).
sandoglobuline i.v 3 g
mediline ltd. - immunoglobulin normal human 3 g/vial - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinaemia or hypogammaglobulinaemia). idiopathic thrombocytopenic purpura (itp).
protelos
mediline ltd. - strontium ranelate 2 g - granules for oral suspension - strontium ranelate - treatment of postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures.
medikinet mr 20 mg modified-release capsules
mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.
medikinet mr 30 mg modified-release capsules
mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.
medikinet mr 40 mg modified-release capsules
mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.